• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎患者停用免疫抑制化疗后的急性肝损伤

Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.

作者信息

Pinto P C, Hu E, Bernstein-Singer M, Pinter-Brown L, Govindarajan S

机构信息

Department of Medicine, Los Angeles County University of Southern California Medical Center.

出版信息

Cancer. 1990 Feb 15;65(4):878-84. doi: 10.1002/1097-0142(19900215)65:4<878::aid-cncr2820650409>3.0.co;2-k.

DOI:10.1002/1097-0142(19900215)65:4<878::aid-cncr2820650409>3.0.co;2-k
PMID:2297658
Abstract

Five patients with lymphoproliferative malignancies and chronic hepatitis B suffered severe acute hepatic injury after the withdrawal of multiagent chemotherapy that included high-dose corticosteroid. Four patients died of hepatic failure, three of whom received corticosteroid as treatment for the hepatic injury. We believe that the cause of this entity is massive immune-associated cytolysis of hepatitis B virus infected hepatocytes occurring after a period of immunosuppression and increased viral replication. The literature regarding this complication of chemotherapy and its pathophysiology is reviewed.

摘要

五例患有淋巴增殖性恶性肿瘤且慢性乙型肝炎的患者在停用包含大剂量皮质类固醇的多药联合化疗后,出现了严重的急性肝损伤。四名患者死于肝衰竭,其中三名接受了皮质类固醇治疗肝损伤。我们认为,这种情况的病因是在一段免疫抑制及病毒复制增加之后,乙肝病毒感染的肝细胞发生了大量免疫相关的细胞溶解。本文对有关化疗这一并发症及其病理生理学的文献进行了综述。

相似文献

1
Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.乙型肝炎患者停用免疫抑制化疗后的急性肝损伤
Cancer. 1990 Feb 15;65(4):878-84. doi: 10.1002/1097-0142(19900215)65:4<878::aid-cncr2820650409>3.0.co;2-k.
2
Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.丙型肝炎病毒感染患者在接受血液系统恶性肿瘤化疗时出现的肝功能障碍。
Cancer. 1998 Sep 15;83(6):1224-30.
3
Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy.接受化疗的非霍奇金淋巴瘤患者中的暴发性肝衰竭
Eur J Cancer. 1992;28A(8-9):1338-9. doi: 10.1016/0959-8049(92)90513-2.
4
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.乙肝表面抗原阴性/乙肝核心抗体阳性患者接受利妥昔单抗联合化疗而未常规进行抗病毒预防时乙型肝炎病毒(HBV)再激活的风险。
Ann Hematol. 2011 Oct;90(10):1219-23. doi: 10.1007/s00277-011-1241-0. Epub 2011 Apr 26.
5
Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.非霍奇金淋巴瘤患者接受周期性化疗期间的急性肝毒性
Haematologica. 1997 Jan-Feb;82(1):38-42.
6
Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.前瞻性评估接受化疗的淋巴瘤患者中血清阳性隐匿性乙型肝炎病毒感染。
Hong Kong Med J. 2011 Oct;17(5):376-80.
7
Hepatitis B infection in patients with lymphomas.淋巴瘤患者中的乙型肝炎感染
Hematol Oncol. 1990 Sep-Oct;8(5):261-70. doi: 10.1002/hon.2900080504.
8
Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier.一名乙肝病毒携带者化疗停药后发生大规模肝坏死。
Arch Intern Med. 1985 Jul;145(7):1313-4.
9
Acute liver failure due to hepatic involvement by hematologic malignancy.血液系统恶性肿瘤累及肝脏导致的急性肝衰竭。
Dig Dis Sci. 1997 Jul;42(7):1400-5. doi: 10.1023/a:1018889904839.
10
Risk factors for damaged liver function after chemotherapy in hepatitis B virus carriers with non-Hodgkin lymphoma.乙型肝炎病毒携带者非霍奇金淋巴瘤化疗后肝功能受损的危险因素
Genet Mol Res. 2015 Mar 30;14(1):2647-53. doi: 10.4238/2015.March.30.25.

引用本文的文献

1
Management of hepatitis B reactivation in patients receiving cancer chemotherapy.乙型肝炎病毒再激活患者在接受癌症化疗时的管理。
Therap Adv Gastroenterol. 2012 Sep;5(5):359-70. doi: 10.1177/1756283X12450245.
2
Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists.目前对接受实体瘤化疗患者进行乙型肝炎再激活的筛查实践和临床经验:一项对肿瘤内科医生的全国性调查。
J Oncol Pract. 2011 May;7(3):141-7. doi: 10.1200/JOP.2010.000133.
3
Rituximab administration and reactivation of HBV.
利妥昔单抗的使用与乙肝病毒再激活
Hepat Res Treat. 2010;2010:182067. doi: 10.1155/2010/182067. Epub 2010 Dec 1.
4
Association between hepatitis B virus and pancreatic cancer.乙型肝炎病毒与胰腺癌之间的关联。
J Clin Oncol. 2008 Oct 1;26(28):4557-62. doi: 10.1200/JCO.2008.17.3526.
5
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.对接受细胞毒性化疗的癌症患者中与乙型肝炎病毒(HBV)再激活相关的危险因素的综合分析。
Br J Cancer. 2004 Apr 5;90(7):1306-11. doi: 10.1038/sj.bjc.6601699.
6
Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.
Int J Hematol. 2004 Feb;79(2):165-73. doi: 10.1532/ijh97.03115.
7
Extrahepatic manifestations of chronic viral hepatitis.慢性病毒性肝炎的肝外表现
Curr Gastroenterol Rep. 2001 Feb;3(1):71-8. doi: 10.1007/s11894-001-0044-1.
8
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.
Dig Dis Sci. 1998 Oct;43(10):2267-70. doi: 10.1023/a:1026622807373.
9
Acute exacerbation of hepatitis due to reactivation of hepatitis B virus with mutations in the core region after chemotherapy for malignant lymphoma.恶性淋巴瘤化疗后乙肝病毒核心区突变再激活导致的急性肝炎加重
J Gastroenterol. 1997 Oct;32(5):668-71. doi: 10.1007/BF02934119.